Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

JOHNSON & JOHNSON Director's Dealing 2025

Feb 12, 2025

29750_dirs_2025-02-11_8711a951-a81e-4655-9c04-1b9e0426269c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2025-02-07

Reporting Person: Wolk Joseph J (Exec VP, CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-07 Common Stock M 13015 $100.06 Acquired 13015 Direct
2025-02-07 Common Stock S 13015 $153.89 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-07 Employee Stock Options (Right to Buy) $100.06 M 13015 Disposed 2025-02-09 Common Stock (13015) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 68835 Indirect
Common Stock 2113 Indirect

Footnotes

F1: Reflects the exercise of options immediately prior to their expiration.

F2: This transaction was executed in multiple trades at prices ranging from $153.86 to $153.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: Held in a spousal lifetime access trust, of which the reporting person's spouse is the trustee and beneficiary.

F4: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).